A MAJOR new partnership has been struck between Wye Valley NHS Trust and Sensyne Health.
British clinical artificial intelligence technology company Sensyne Health announced on January 28 that it had signed a Strategic Research Agreement with the hospital trust.
The agreement allows the company to analyse anonymised patient datasets covering 1.36 million hospital admissions using clinical artificial intelligence technology with the aim of deriving new insights to improve patient care and develop new treatments.
Wye Valley NHS Trust will receive a £2.5 million equity stake in Sensyne Health and will benefit from royalties that arise from any medical discoveries made.
Company chief executive Lord Peter Drayson said: “We are delighted that Wye Valley NHS Trust has joined our research partnership in clinical AI alongside South Warwickshire, Oxford University Hospitals and Chelsea and Westminster NHS Trusts.
“Together, we aim to make new discoveries that will improve care for patients, accelerate medical research and provide a return back into the NHS.”